Elotuzumab in the treatment of relapsed and refractory multiple myeloma

Grosicki, S; Bednarczyk, M; Barchnicka, A; Grosicka, O

Grosicki, S (corresponding author), Med Univ Silesia, Fac Hlth Sci, Dept Hematol & Canc Prevent, PL-40055 Katowice, Poland.

FUTURE ONCOLOGY, 2021; 17 (13): 1581

Abstract

Lay abstract Multiple myeloma remains an incurable cancer. The essential concerns are the high relapse rate and the developing resistance to treatment......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索